Corcept Therapeutics Incorporated shares owned by Birchview Capital
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Birchview Capital
from 13F filings
Historical chart of Birchview Capital investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Birchview Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.4M | 74k | 46.28 |
| 2024-06-30 | $2.4M | 74k | 32.49 |
| 2024-03-31 | $1.3M | 50k | 25.19 |
| 2023-12-31 | $1.6M | 50k | 32.48 |
| 2023-09-30 | $1.4M | 50k | 27.25 |
| 2023-06-30 | $1.1M | 50k | 22.25 |
| 2023-03-31 | $1.1M | 50k | 21.66 |
| 2022-12-31 | $1.0M | 50k | 20.32 |
| 2022-09-30 | $1.3M | 50k | 25.64 |
| 2022-06-30 | $1.2M | 50k | 23.78 |
| 2022-03-31 | $1.1M | 50k | 22.52 |
| 2021-12-31 | $990k | 50k | 19.80 |
| 2021-09-30 | $984k | 50k | 19.68 |
| 2021-06-30 | $1.1M | 50k | 22.00 |
| 2021-03-31 | $1.2M | 50k | 23.80 |
| 2020-12-31 | $1.3M | 50k | 26.16 |
| 2020-09-30 | $870k | 50k | 17.40 |
| 2020-06-30 | $841k | 50k | 16.82 |
| 2020-03-31 | $594k | 50k | 11.88 |
| 2019-12-31 | $605k | 50k | 12.10 |
| 2019-09-30 | $707k | 50k | 14.14 |
| 2019-06-30 | $558k | 50k | 11.16 |
| 2019-03-31 | $587k | 50k | 11.74 |
| 2018-12-31 | $668k | 50k | 13.36 |
| 2018-09-30 | $701k | 50k | 14.02 |
| 2018-06-30 | $786k | 50k | 15.72 |
| 2018-03-31 | $1.2M | 76k | 16.45 |
| 2017-12-31 | $1.7M | 95k | 18.06 |
| 2017-09-30 | $1.8M | 95k | 19.31 |
| 2017-06-30 | $1.1M | 95k | 11.80 |
| 2017-03-31 | $658k | 60k | 10.97 |
| 2016-12-31 | $581k | 80k | 7.26 |
| 2016-09-30 | $520k | 80k | 6.50 |
| 2016-06-30 | $437k | 80k | 5.46 |
| 2016-03-31 | $374k | 80k | 4.68 |
| 2015-12-31 | $398k | 80k | 4.98 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated